VANCOUVER, British Columbia — Semaphore Solutions, a leader in laboratory informatics solutions, announces a new investment from Cypress Ridge Capital (“CRC”) to further accelerate the growth of its flagship platform, Labbit. The growth equity investment builds on Cypress Ridge’s initial investment in February 2023 and supports the continued organic and inorganic expansion of Labbit as […]
FARMINGDALE, N.Y. — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, […]
Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of next-generation diagnostics. Secured $25M in funding from F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics. MIAMI — Galatea Bio, a leader in AI-driven genomic research […]
mo:re introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models. The user-friendly platform enables verifiable, standardized results without requiring expertise in specific organ systems. The Hamburg-based life science start-up mo:re announced the launch of their first product at the SLAS 2025 in San Diego, the world’s leading […]
2024 was characterized by continuity for INTEGRA Biosciences. With sales of CHF 156 million, the company remained at the previous year’s level despite a difficult first quarter. Compared to the period before the COVID-19 pandemic, the company has doubled in size, underlining its sustainable growth. Agility and growth in a challenging market environment The market […]
Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]
SAN DIEGO — Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced that it has entered into a convertible preferred stock purchase agreement (the Purchase Agreement) to sell shares of a new series of convertible preferred stock in a private […]
Aptco Group has entered into a strategic partnership with Tilleghem, a private equity investment company based in Ghent, Belgium, whereby Tilleghem has acquired a minority stake in Aptco Group. This collaboration marks a significant step in Aptco Group’s growth trajectory, positioning the company for accelerated international expansion and long-term success. The daily operations and responsibilities […]
AI platform combined with autonomous labs will accelerate discovery across every domain of science Company has raised $200M in seed financing to further develop platform and build first AI Science Factories CAMBRIDGE, MA – Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world’s first scientific superintelligence platform and fully […]
Investment lead by Foresight Group secured alongside Polish grant funding agency PARP Scottishbiotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by the Foresight Group. Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production,offering […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
